Intro

Easy 20–30 Minute Procedure

A quick, painless same-day surgery to help you achieve better vision.

Pre-Op Eye Exam

Before you schedule your EVO ICL lens (EVO) procedure your doctor will perform a series of standard tests to measure your eye’s unique characteristics for the procedure. Once your doctor determines that EVO ICL is a good option for you, they will educate you about the procedure and what to expect both during and after the procedure.

Getting Your EVO ICLs

When you arrive for your procedure your doctor will administer eye drops to dilate your pupils as well as anaesthetise your eyes.

Small Opening

To prepare for the implant your doctor will create one small opening at the base of your cornea to insert the EVO ICL lens. The procedure is painless because of the numbing medication.

Lens Insertion & Positioning

The EVO ICL lens then can be folded and inserted through the small incision your doctor has made. Once the lens is inserted the doctor will make any necessary adjustments to ensure proper positioning in the eye.

Returning Home

At this point, the procedure is over and many patients will have improved vision nearly immediately. Your doctor will prescribe more eye drops intended to aid in the healing process following the procedure. You will need someone to drive you home, your doctor will tell you when your vision allows driving.

Cost blocks

How much does the EVO ICL procedure cost? Is it more expensive than LASIK?

On Average CDN$14,000 Over Lifetime* Your personal cost will vary.

Because EVO ICL is a long-term solution, your procedure costs are generally fixed to a one-time-fee. When you compare with the long-term costs of contact lenses, EVO ICL pays for itself.

*Popular daily disposable contacts, on average, cost about CDN$730 a year. So over 20 years, a patient will spend CDN$14,000 on contact lenses.

Candidate desktop

Who is a Good Candidate for EVO ICL?

EVO ICL Candidates

  • Are between 21 and 60 years old.
  • Are near-sighted with mild to severe myopia (-0.5D to -20D).
  • Are farsighted with mild to severe hyperopia (+0.5D to +10.0D)
  • Have astigmatism between 0.5 and 6.0 D
  • Have not had a change in prescription of more than .5D in a year.
  • Are looking for a procedure that doesn’t create dry eye syndrome.

Real Life Stories From Real Life Patients

The thing that I love about the Visian ICL is that they are putting a lens in there that can be removed.

Jennifer Puno, Web Designer

I feel like a big part of health is using what your body already has. Visian ICL is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie, Jiu Jitsu Instructor

I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmer's market.

Sara Tso, Chef

There’s a few big road blocks to having glasses and being a photographer. Now I’ve got Visian ICL and I can run out and live my life unhindered.

Andrew Oxenham, Photographer

I had my first opportunity to put my Visian ICL eyes to the test recently in the Amazon rainforest, and it couldn't have been more exciting to be able to spot rare species better than ever.

Phil Torres, Entomologist, TV Show Host

2 Million+

Lenses Distributed

99.4%

of people surveyed would have the procedure again¹

Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today

Important Safety Information

The EVO Visian ICL & EVO Visian TICL is designed for the correction/reduction of myopia in adults ranging from -0.5 D to -20.0 D with less than or equal to 6.0 D of astigmatism at the spectacle plane. The Canada EVO Visian models have a spherical power range of -3.0 D to -18.0 D and cylinder power range of 1.0 D to 6.0 D. The Canada EVO Visian ICL models have a spherical power range of -3.0 D to -14.0 D and cylinder power range of 1.0 D to 6.0 D. The hyperopic EVO Visian ICL’s are available in powers ranging from +3.0 to +10.0 diopters for the correction/reduction of hyperopia. The ICLs are indicated for patients who are 21 to 60 years of age. In order to be sure that your surgeon will use a EVO Visian ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. EVO Visian ICL surgery may improve your vision without eyeglasses or contact lenses. EVO Visian ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. EVO Visian ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO Visian ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

References

Find a Doctor

References

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council